{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:27:40Z","timestamp":1760131660907},"reference-count":34,"publisher":"American Society for Microbiology","issue":"7","license":[{"start":{"date-parts":[[2004,7,1]],"date-time":"2004-07-01T00:00:00Z","timestamp":1088640000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2004,7]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>Platelets contribute to antimicrobial host defense against infective endocarditis (IE) by releasing platelet microbicidal proteins (PMPs). We investigated the influence of thrombin-stimulated human platelets on the evolution of simulated IE in the presence and absence of vancomycin or nafcillin.<jats:italic>Staphylococcus aureus<\/jats:italic>strains differing in intrinsic susceptibility to PMPs or antibiotics were studied: ISP479C (thrombin-induced PMP-1 [tPMP-1] susceptible; nafcillin and vancomycin susceptible), ISP479R (tPMP-1 resistant; nafcillin and vancomycin susceptible), and GISA-NJ (tPMP-1 intermediate-susceptible; vancomycin intermediate-susceptible). Platelets were introduced and thrombin activated within the in vitro IE model 30 min prior to inoculation with<jats:italic>S. aureus<\/jats:italic>. At 0 to 24 h postinoculation, bacterial densities in chamber fluid and simulated endocardial vegetations (SEVs) were quantified and compared among groups. Activated platelets alone, or in combination with antibiotics, inhibited the proliferation of ISP479C in chamber fluid or SEVs over the initial 4-h period (<jats:italic>P<\/jats:italic>&lt; 0.05 versus controls). Moreover, nafcillin-containing regimens exerted inhibitory effects beyond 4 h against ISP479C in both model phases. By comparison, activated platelets inhibited GISA-NJ proliferation in SEVs but not in chamber fluid. The combination of platelets plus nafcillin or vancomycin significantly inhibited proliferation of the GISA-NJ strain in SEVs compared to the effect of platelets or antibiotics alone (<jats:italic>P<\/jats:italic>&lt; 0.05). In contrast, platelets did not significantly alter the antistaphylococcal efficacies of nafcillin or vancomycin against ISP479R. These data support our hypothesis that a beneficial antimicrobial effect may result from the interaction among platelets, PMPs, and anti-infective agents against antibiotic-susceptible or -resistant staphylococci that exhibit a tPMP-1-susceptible or -intermediate-susceptible phenotype.<\/jats:p>","DOI":"10.1128\/aac.48.7.2551-2557.2004","type":"journal-article","created":{"date-parts":[[2004,6,23]],"date-time":"2004-06-23T22:18:08Z","timestamp":1088029088000},"page":"2551-2557","update-policy":"http:\/\/dx.doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":24,"title":["Beneficial Influence of Platelets on Antibiotic Efficacy in an In Vitro Model of<i>Staphylococcus aureus<\/i>-Induced Endocarditis"],"prefix":"10.1128","volume":"48","author":[{"given":"Renee-Claude","family":"Mercier","sequence":"first","affiliation":[{"name":"University of New Mexico\u2014College of Pharmacy, Albuquerque, New Mexico 87131"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert M.","family":"Dietz","sequence":"additional","affiliation":[{"name":"University of New Mexico\u2014College of Pharmacy, Albuquerque, New Mexico 87131"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jory L.","family":"Mazzola","sequence":"additional","affiliation":[{"name":"University of New Mexico\u2014College of Pharmacy, Albuquerque, New Mexico 87131"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arnold S.","family":"Bayer","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, St. John's Cardiovascular Research Center, Research and Education Institute at Harbor UCLA Medical Center, Torrance, California 90502"},{"name":"David Geffen School of Medicine, University of California, Los Angeles, California 90024"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael R.","family":"Yeaman","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, St. John's Cardiovascular Research Center, Research and Education Institute at Harbor UCLA Medical Center, Torrance, California 90502"},{"name":"David Geffen School of Medicine, University of California, Los Angeles, California 90024"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.63.9.3634-3641.1995"},{"key":"e_1_3_2_3_2","first-page":"624","volume":"46","year":"1997","unstructured":"Centers for Disease Control and Prevention. 1997. Reduced susceptibility of Staphylococcus aureus to vancomycin\u2014Japan 1996. Morb. Mortal. Wkly. Rep.46:624-626.","journal-title":"Morb. Mortal. Wkly. Rep."},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.66.7.3476-3479.1998"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.44.11.3206-3209.2000"},{"key":"e_1_3_2_6_2","first-page":"44","volume":"53","year":"1972","unstructured":"Durack, D. T., and P. B. Besson. 1972. Experimental bacterial endocarditis. I. Colonization of a sterile vegetation. Br. J. Exp. Pathol.53:44-49.","journal-title":"Br. J. Exp. Pathol."},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.44.7.1921-1924.2000"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/40.1.135"},{"key":"e_1_3_2_9_2","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/(SICI)1521-4028(199811)38:5\/6<383::AID-JOBM383>3.0.CO;2-J","volume":"38","year":"1998","unstructured":"Hostacka, A. 1998. Serum sensitivity and cell surface hydrophobicity of Klebsiella pneumoniae treated with gentamicin, tobramycin, and amikacin. J. Basic Microbiol.38:383-388.","journal-title":"J. Basic Microbiol."},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.39.7.1505"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.39.5.1054"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1161\/hc0602.103721"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.68.8.4699-4705.2000"},{"key":"e_1_3_2_14_2","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1159\/000239443","volume":"42","year":"1996","unstructured":"Miglioli, P. A., U. Schoffel, and L. Gianfranceschi. 1996. The in vitro synergistic inhibitory effect of human amniotic fluid and gentamicin on growth of Escherichia coli. Chemotherapy42:206-209.","journal-title":"Chemotherapy"},{"key":"e_1_3_2_15_2","unstructured":"National Committee for Clinical Laboratory Standards. 2000. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically 5th ed. Approved standard M7-A5. National Committee for Clinical Laboratory Standards Wayne Pa."},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.36.1.10"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.41.6.1359"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/168.4.910"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.70.12.6524-6533.2002"},{"key":"e_1_3_2_20_2","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.4049\/jimmunol.132.5.2582","volume":"132","year":"1984","unstructured":"Vaara, M., P. Viljanen, T. Vaara, and P. H. Makela. 1984. An outer membrane-disorganizing peptide PMBN sensitizes Escherichia coli to serum bactericidal action. J. Immunol.132:2582-2589.","journal-title":"J. Immunol."},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1139\/m86-013"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.38.4.729"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1086\/338514"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.45.5.1558-1560.2001"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1086\/516120"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.37.3.546"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.36.8.1665"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.60.6.2368-2374.1992"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.60.3.1202-1209.1992"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.64.4.1379-1384.1996"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.62.8.3416-3423.1994"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.38.7.1460"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/166.1.65"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.65.3.1023-1031.1997"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2001-12-0191"}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.48.7.2551-2557.2004","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.48.7.2551-2557.2004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T22:13:11Z","timestamp":1682719991000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.48.7.2551-2557.2004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,7]]},"references-count":34,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2004,7]]}},"alternative-id":["10.1128\/AAC.48.7.2551-2557.2004"],"URL":"https:\/\/doi.org\/10.1128\/aac.48.7.2551-2557.2004","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,7]]},"assertion":[{"value":"2003-09-15","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2004-03-12","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2004-07-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}